Roche Holding AG (ROP.SW) — the peer cohort

As of 2026-10-24 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Roche Holding AG ranks 16 of 16 in its cohort on the Closelooknet composite (56/100) — the cohort is led by BB Biotech AG at 74/100.

Name	Composite	Momentum	Quality	Valuation	Signal	Off 52w high
ROP.SW Roche Holding AG	56	79	84	56	ok	1%
BION.SW BB Biotech AG	74	62	96	82	info	14.6%
HALO Halozyme Therapeutics Inc	74	98	94	48	ok	0.5%
ONC BeiGene, Ltd.	65	86	64	31	ok	2.8%
DXCM DexCom Inc	65	77	80	36	bear	15.8%
LLY Eli Lilly and Company	65	83	91	27	watch	3.6%
UCB.BR UCB SA	65	65	71	55	info	5.4%
ANN.AU Ansell Ltd	64	96	47	57	ok	0.5%
ARGX.BR Argen-X	64	73	75	30	info	15.4%
MEDP Medpace Holdings Inc	64	91	75	29	ok	2.2%
ARGX argenx NV ADR	63	66	74	29	info	18.6%
HQY HealthEquity Inc	63	80	70	45	info	3.4%
ORNAV.HE Orion Oyj A	63	88	84	33	ok	0.5%
ORNBV.HE Orion Oyj B	63	88	84	33	ok	0.2%
ROVI.MC Laboratorios Farmaceuticos ROVI	62	32	77	51	info	29.4%
RIGL Rigel Pharmaceuticals Inc	62	92	90	74	ok	7.9%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-24

Quick answers

Who are Roche Holding AG's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: BB Biotech AG (BION.SW), Halozyme Therapeutics Inc (HALO), BeiGene, Ltd. (ONC), DexCom Inc (DXCM), Eli Lilly and Company (LLY), UCB SA (UCB.BR), Ansell Ltd (ANN.AU), Argen-X (ARGX.BR) and others.

How does ROP.SW score against its peers?

Roche Holding AG's composite reads 56/100, ranking 16 of 16 in its cohort as of 2026-10-24; the cohort's highest composite is BB Biotech AG at 74/100. Closelooknet scores are research diary readings, not ratings or advice.